Why KRAS mutations prevail in colorectal, lung and pancreatic cancer, while NRAS or BRAF are mutated more frequently in skin melanoma, and HRAS mutations are predominant in head and neck squamous cell carcinoma is not yet clear. This evidence concerns the gene KRAS and pancreatic neoplasm.